Abstract
Genetic Engineering & Biotechnology NewsVol. 41, No. 10 CommentaryThose Were the Early Days My Friend, We Thought They'd Never EndRecalling the founding of Genetic Systems, a monoclonal antibody company that helped incite the biotech revolutionDavid BlechDavid BlechDavid Blech is an American businessman, investor, and venture capitalist. He was a financial pioneer of the biotech industry and was once known as the “King of Biotech.” Blech made the Fortune 400 list in 1992 with a net worth of $300 million.Search for more papers by this authorPublished Online:6 Oct 2021https://doi.org/10.1089/gen.41.10.19AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 41Issue 10Oct 2021 Information© 2021 by GEN PublishingTo cite this article:David Blech.Those Were the Early Days My Friend, We Thought They'd Never End.Genetic Engineering & Biotechnology News.Oct 2021.54-55.http://doi.org/10.1089/gen.41.10.19Published in Volume: 41 Issue 10: October 6, 2021PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
